Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
Candida lusitaniae is an emerging fungal pathogen that infects immunocompromised patients including HIV/AIDS, cancer, and neonatal pediatric patients. Though less prevalent than other Candida species, C. lusitaniae is unique in its ability to develop resistance to amphotericin B. We investigated the...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3432075?pdf=render |
id |
doaj-61147729c117437baca63a78ae53f2f1 |
---|---|
record_format |
Article |
spelling |
doaj-61147729c117437baca63a78ae53f2f12020-11-25T00:23:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4419210.1371/journal.pone.0044192Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.Jing ZhangFitz Gerald S SilaoUrsela G BigolAlice Alma C BungayMarilou G NicolasJoseph HeitmanYing-Lien ChenCandida lusitaniae is an emerging fungal pathogen that infects immunocompromised patients including HIV/AIDS, cancer, and neonatal pediatric patients. Though less prevalent than other Candida species, C. lusitaniae is unique in its ability to develop resistance to amphotericin B. We investigated the role of the calcium-activated protein phosphatase calcineurin in several virulence attributes of C. lusitaniae including pseudohyphal growth, serum survival, and growth at 37°C. We found that calcineurin and Crz1, a C. albicans Crz1 homolog acting as a downstream target of calcineurin, are required for C. lusitaniae pseudohyphal growth, a process for which the underlying mechanism remains largely unknown in C. lusitaniae but hyphal growth is fundamental to C. albicans virulence. We demonstrate that calcineurin is required for cell wall integrity, ER stress response, optimal growth in serum, virulence in a murine systemic infection model, and antifungal drug tolerance in C. lusitaniae. To further examine the potential of targeting the calcineurin signaling cascade for antifungal drug development, we examined the activity of a calcineurin inhibitor FK506 in combination with caspofungin against echinocandin resistant C. lusitaniae clinical isolates. Broth microdilution and drug disk diffusion assays demonstrate that FK506 has synergistic fungicidal activity with caspofungin against echinocandin resistant isolates. Our findings reveal that pseudohyphal growth is controlled by the calcineurin signaling cascade, and highlight the potential use of calcineurin inhibitors and caspofungin for emerging drug-resistant C. lusitaniae infections.http://europepmc.org/articles/PMC3432075?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jing Zhang Fitz Gerald S Silao Ursela G Bigol Alice Alma C Bungay Marilou G Nicolas Joseph Heitman Ying-Lien Chen |
spellingShingle |
Jing Zhang Fitz Gerald S Silao Ursela G Bigol Alice Alma C Bungay Marilou G Nicolas Joseph Heitman Ying-Lien Chen Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. PLoS ONE |
author_facet |
Jing Zhang Fitz Gerald S Silao Ursela G Bigol Alice Alma C Bungay Marilou G Nicolas Joseph Heitman Ying-Lien Chen |
author_sort |
Jing Zhang |
title |
Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. |
title_short |
Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. |
title_full |
Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. |
title_fullStr |
Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. |
title_full_unstemmed |
Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. |
title_sort |
calcineurin is required for pseudohyphal growth, virulence, and drug resistance in candida lusitaniae. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
Candida lusitaniae is an emerging fungal pathogen that infects immunocompromised patients including HIV/AIDS, cancer, and neonatal pediatric patients. Though less prevalent than other Candida species, C. lusitaniae is unique in its ability to develop resistance to amphotericin B. We investigated the role of the calcium-activated protein phosphatase calcineurin in several virulence attributes of C. lusitaniae including pseudohyphal growth, serum survival, and growth at 37°C. We found that calcineurin and Crz1, a C. albicans Crz1 homolog acting as a downstream target of calcineurin, are required for C. lusitaniae pseudohyphal growth, a process for which the underlying mechanism remains largely unknown in C. lusitaniae but hyphal growth is fundamental to C. albicans virulence. We demonstrate that calcineurin is required for cell wall integrity, ER stress response, optimal growth in serum, virulence in a murine systemic infection model, and antifungal drug tolerance in C. lusitaniae. To further examine the potential of targeting the calcineurin signaling cascade for antifungal drug development, we examined the activity of a calcineurin inhibitor FK506 in combination with caspofungin against echinocandin resistant C. lusitaniae clinical isolates. Broth microdilution and drug disk diffusion assays demonstrate that FK506 has synergistic fungicidal activity with caspofungin against echinocandin resistant isolates. Our findings reveal that pseudohyphal growth is controlled by the calcineurin signaling cascade, and highlight the potential use of calcineurin inhibitors and caspofungin for emerging drug-resistant C. lusitaniae infections. |
url |
http://europepmc.org/articles/PMC3432075?pdf=render |
work_keys_str_mv |
AT jingzhang calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae AT fitzgeraldssilao calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae AT urselagbigol calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae AT alicealmacbungay calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae AT marilougnicolas calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae AT josephheitman calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae AT yinglienchen calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae |
_version_ |
1725355874301509632 |